LECANEMAB RECEIVES PRIORITY REVIEW STATUS IN JAPAN ...Middle East

TOKYO and CAMBRIDGE, Mass., January 29, 2023 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, "Biogen") announced today that an application for...

Hence then, the article about lecanemab receives priority review status in japan was published today ( Monday 30/01/2023 - 02:52 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( LECANEMAB RECEIVES PRIORITY REVIEW STATUS IN JAPAN )

Also on site :

• Russian MOD shows map of Ukrainian drone attack on Putin’s residence
• Advantech Unveils Next-Generation Edge AI Compute Solutions Powered by Qualcomm Dragonwing IQ-X Series
• From collapse fears to resilience: How Russia reshaped its economy by the end of 2025